Breast Cancer Now Nina Barough Pathology Core Facility

The Breast Cancer Now Nina Barough Pathology Core Facility provides diagnostic and research-based histopathology to both the Breast Cancer Now Research Centre and research teams within The Institute of Cancer Research.

Photo: Jan Chlebik/the ICR 

The modern laboratory is well-equipped laboratory and offers a comprehensive repertoire of histological services, including tissue processing, embedding, and cutting of clinical or animal material. The laboratory is equipped with two auto-stainers for immunohistochemical detection, and a semi-automatic tissue arrayer for constructing tissue microarrays from clinical or research material.

While the facility’s priority is to Breast Cancer Now scientists, they also offer advice in histopathological technique to researchers within the ICR.

For more information, please contact the Core Facility Manager, Naomi Guppy.

Multiple trays of small, transparent containers or vials filled with liquids
Scientists find new way to predict how bowel cancer drugs will stop working

20/06/25

Scientists from The Institute of Cancer Research, London, have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer.
See full story
Elen Hughes (credit: Elen Hughes)
“New breast cancer drug capivasertib is allowing me to live life to the full” – Elen’s story

27/06/25 - Elen Hughes

Elen Hughes was first diagnosed with primary invasive lobular breast cancer in 2008 at the age of 37. Eight years later, her cancer returned and spread, and she has been on a rollercoaster journey ever since, experiencing the highs of remission and the lows of numerous relapses. Since February 2025, she has been treated with the drug capivasertib, the discovery of which was underpinned by research at The Institute of Cancer Research. She is now doing well and feels hopeful for her future.
See full story